Ronald E. Lieberman

Emergency Medicine

13222 Bloomfield Ave
Norwalk, CA 90650

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer.

An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer.

Journal: Clinical lung cancer

Published: July 18, 2014

Cardiovascular safety monitoring during oncology drug development and therapy.

Cardiovascular safety monitoring during oncology drug development and therapy.

Journal: American journal of therapeutics

Published: January 24, 2014

Showing 1-2 of 2

Last Updated: 09/26/2026